IGC Pharma, Inc. (IGC) Financials
IGC Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 11.3 million | 2.2 million |
| 2023-09-30 | 16.5 million | 2.4 million |
| 2023-06-30 | 17.2 million | 2.3 million |
| 2023-03-31 | 17.2 million | 2.3 million |
IGC Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -1.7 million | 526000 |
| 2023-09-30 | -1.7 million | 550000 |
| 2023-06-30 | -2.0 million | 583000 |
| 2023-03-31 | -2.0 million | 583000 |
IGC Net Income
No data available :(
IGC Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 1.4 million | - | 239000 |
| 2023-09-30 | 3.1 million | - | 276000 |
| 2023-06-30 | 3.4 million | 140000 | 308000 |
| 2023-03-31 | 3.4 million | 141000 | 340000 |
IGC Shares Outstanding
IGC Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 87000 | 903000 | 2.2 million | - |
| 2023-09-30 | 55000 | 1.3 million | 1.4 million | - |
| 2023-06-30 | 475000 | 493000 | 1.9 million | 1.8 million |
| 2023-03-31 | 228000 | 493000 | 3.2 million | - |
IGC Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 204000 | 211000 |
| 2023-09-30 | 291000 | 117000 |
| 2023-06-30 | 166000 | 103000 |
| 2023-03-31 | 166000 | 103000 |
IGC
Price: $0.55
52 week price:
Earnings Per Share: -0.26 USD
P/E Ratio: -1.43
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Volume: 122069
Market Capitalization: 40.8 million